U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205510) titled 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)' on Aug. 28.
Brief Summary: This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.
Study Start Date: Dec. 01, 2020
Study Type: OBSERVATIONAL
Condition:
Sarcopenia
Metabolic Diseases
All-cause Mortality...